Abstract:Background The pentose phosphate pathway (PPP) plays a crucial role in the material and energy metabolism in cancer cells. Targeting 6-phosphogluconate dehydrogenase (6PGD), the rate-limiting enzyme in the PPP metabolic process, to inhibit cellular metabolism is an effective anticancer strategy. In our previous study, we have preliminarily demonstrated that gambogic acid (GA) induced cancer cell death by inhibiting 6PGD and suppressing PPP at the cellular level. However, it is unclear whether GA could suppress cancer cell growth by inhibiting PPP pathway in mouse model. Purpose This study aimed to confirm that GA as a covalent inhibitor of 6PGD protein and to validate that GA suppresses cancer cell growth by inhibiting the PPP pathway in a mouse model. Methods Cell viability was detected by CCK-8 assays as well as flow cytometry. The protein targets of GA were identified using a chemical probe and activity-based protein profiling (ABPP) technology. The target validation was performed by in-gel fluorescence assay, the Cellular Thermal Shift Assay (CETSA). A lung cancer mouse model was constructed to test the anticancer activity of GA. RNA sequencing was performed to analyze the global effect of GA on gene expression. Results The chemical probe of GA exhibited high biological activity in vitro . 6PGD was identified as one of the binding proteins of GA by ABPP. Our findings revealed a direct interaction between GA and 6PGD. We also found that the anti-cancer activity of GA depended on reactive oxygen species (ROS), as evidenced by experiments on cells with 6PGD knocked down. More importantly, GA could effectively reduce the production of the two major metabolites of the PPP in lung tissue and inhibit cancer cell growth in the mouse model. Finally, RNA sequencing data suggested that GA treatment significantly regulated apoptosis and hypoxia-related physiological processes. Conclusion These results demonstrated that GA was a covalent inhibitor of 6PGD protein. GA effectively suppressed cancer cell growth by inhibiting the PPP pathway without causing significant side effects in the mouse model. Our study provides in vivo evidence that elucidates the anticancer mechanism of GA, which involves the inhibition of 6PGD and modulation of cellular metabolic processes.

Gambogic Acid Potentiates Clopidogrel-Induced Apoptosis and Attenuates Irinotecan-Induced Apoptosis Through Down-Regulating Human Carboxylesterase 1 and -2.

Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.

Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model

Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells.

Gambogic Acid Mediates Apoptosis As a P53 Inducer Through Down-Regulation of Mdm2 in Wild-Type P53-Expressing Cancer Cells

Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation.

Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog.

Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis

Gambogic acid induces apoptosis of lung cancer H1975 cells by activating JNK signaling pathway and upregulating ROS

The natural interaction between gambogic acid and oxaliplatin and its probably mechanism

Synergistic Anti-Proliferative Effects of Gambogic Acid with Docetaxel in Gastrointestinal Cancer Cell Lines

Gambogenic acid induction of apoptosis in a breast cancer cell line.

Gambogic Acid Induces GSDME Dependent Pyroptotic Signaling Pathway Via ROS/P53/Mitochondria/Caspase-3 in Ovarian Cancer Cells

AMPK Activator AICAR Promotes 5-Fu-induced Apoptosis in Gastric Cancer Cells

Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study.

Gambogic acid-induced autophagy in nonsmall cell lung cancer NCI-H441 cells through a reactive oxygen species pathway

Proteomic and Bioinformatic Analyses of Possible Target-Related Proteins of Gambogic Acid in Human Breast Carcinoma MDA-MB-231 Cells.

Gambogic Acid Induces Death Of K562 Cells Through Autophagy And Apoptosis Mechanisms

GA3, a New Gambogic Acid Derivative, Exhibits Potent Antitumor Activities in Vitro Via Apoptosis-Involved Mechanisms

Gambogic Acid-Loaded PEG-PCL Nanoparticles Act As an Effective Antitumor Agent Against Gastric Cancer

Autophagy Inhibition Promotes Gambogic Acid-Induced Suppression Of Growth And Apoptosis In Glioblastoma Cells